Drug Type Small molecule drug |
Synonyms- |
Target |
Action activators |
Mechanism glucokinase activators(Glucokinase activators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H20F2N2O6 |
InChIKeyONHAZCJPHPIFHW-ZDUSSCGKSA-N |
CAS Registry854001-88-0 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | New Zealand | 01 Jun 2011 |





